Form 4: Quaker Chemical VP Dassing Reports Equity Transactions

Steven R. Dassing, VP and Principal Accounting Officer at Quaker Chemical Corp, reported the vesting of performance and restricted stock units, settlement of dividend equivalent rights, and new RSU grants.

Summary

• Steven R. Dassing, VP, Principal Accounting Officer, reported multiple equity transactions on March 15, 2026.
• Acquired 39 shares of common stock from the vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, based on achieving adjusted return on invested capital (ROIC) metrics.
• Acquired a total of 298 shares of common stock (45 + 82 + 171) from the conversion of Restricted Stock Units (RSUs) that vested.
• Acquired 4 shares of common stock from the settlement of Dividend Equivalent Rights (DERs) accrued on previously granted RSUs.
• Disposed of 130 shares of common stock at a price of $118.45 per share to cover tax withholding obligations related to the vesting of restricted stock, RSUs, and PSUs.
• Received new grants of 557 time-based RSUs and 1,266 special time-based RSUs, which will vest in annual installments starting March 15, 2027.
• Following these transactions, Dassing beneficially owns 368 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-slightly positive filing. The vesting of performance-based units indicates successful achievement of a key financial metric, and new RSU grants reinforce long-term executive alignment, though the tax-related share disposition is a routine, non-discretionary event.

Positives

• Vesting of 39 Performance Stock Units (PSUs) indicates the achievement of adjusted return on invested capital (ROIC) metrics over the three-year performance period (March 15, 2023, to March 15, 2026).
• The reporting person received new grants of 557 time-based RSUs and 1,266 special time-based RSUs, demonstrating continued long-term incentive alignment with company performance.

Negatives

• Disposed of 130 shares of common stock at $118.45 to satisfy tax withholding obligations, which reduces direct beneficial ownership.

Future Outlook

The new grants of time-based and special time-based Restricted Stock Units (RSUs) to Steven R. Dassing, vesting in annual installments beginning March 15, 2027, indicate a continued long-term incentive structure for key management.

Industry Context

StockSavvy.ai notes that routine insider transaction filings like this Form 4 are common across industries, reflecting standard executive compensation practices involving equity awards. The vesting of performance-based units tied to ROIC aligns with a broader industry trend of linking executive incentives to specific financial performance metrics.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards indicates management's achievement of certain financial targets, which could be viewed positively. The disposition of shares for tax purposes is a standard event and does not reflect a discretionary sale. New RSU grants align executive interests with long-term shareholder value.
• Employees: The filing details executive compensation, which may indirectly influence broader compensation strategies or morale.

Next Steps

• Annual installments for 557 time-based RSUs to begin vesting on March 15, 2027.
• Annual installments for 1,266 special time-based RSUs to begin vesting on March 15, 2027.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including the vesting of performance and restricted stock units, and the disposition of shares for tax withholding. While the vesting of performance units based on ROIC achievement is a positive indicator of past performance, and new RSU grants align executive incentives, these are standard occurrences and do not present new material information that would significantly alter the investment thesis for Quaker Chemical Corp. Therefore, a 'hold' recommendation is appropriate as the filing does not introduce new factors warranting a change in investment position.

Keywords

Quaker Chemical, KWR, Steven R. Dassing, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, Performance Stock Units, Dividend Equivalent Rights, Equity Compensation, Executive Compensation